ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

27 Jan 2022

Eco Animal Health - Capital Markets Event - Investor Presentation video - 26 January 2022

We were pleased to host the management of ECO Animal Health for a live presentation following their Capital Markets Event on 26th January, focusing on the R&D pipeline, innovation and the company's new product journey.

Marc Loomes (CEO) gave investors an introduction to the company, Dr Hafid Benchaoui (Head of Global R&D) lead viewers through ECO's innovative R&D programme in detail, and Christopher Wilks (CFO) discussed the financial implications. The team also answered a range of questions submitted by investors.

You can see the full video here (with chapter dividers for ease of viewing) - approximate length 73 minutes.

0:47 Introduction - Marc Loomes (CEO)
08:06 R&D programme presentation - Dr Hafid Benchaoui (Head of R&D)
23:32 Poultry vaccines: from idea to best in class products in 5 years
27:01 Game changing porcine biologics
30:04 Innovation in the treatment of respiratory disease
34:12 Financials focus - Christopher Wilks (CFO)
46:26 Questions & Answer discussion

Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 2nd Floor, Park House, 16-18 Finsbury Circus, London, EC2M 7EB

Website design & development by Breckenridge